Navigation Links
Eularis to Address Making the Right Research Decision for ROI
Date:4/21/2008

The Link Between Research and Decisions on Bottom Line Return at 3rd Annual

Pharmaceutical Market Research Summit

NEW YORK and LONDON, April 21 /PRNewswire/ -- Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on Making the Right Research Decision for ROI -- The Link Between Research and Decisions on Bottom Line Return.
*(PHOTO 72dpi: Send2Press.com/mediaboom/08-0421-ABates_72dpi.jpg)

*(Photo Caption: Dr. Andree Bates, president of Eularis.)

WHO: Eularis

WHAT: Presentation on Making the Right Research Decision for ROI - The

Link Between Research and Decisions on Bottom Line Return

WHEN: 29 April 2008 at 11:45 a.m. EDT

WHERE: 3rd Annual Pharmaceutical Market Research Summit

Hyatt Regency at Penn's Landing, Philadelphia

At 11:45 a.m. on Tuesday, 29 April 2008, Dr. Bates will deliver a presentation titled, "How to Tell if You Are Making the Right Research Decision for ROI - The Link Between Research and Decisions on Bottom Line Return." Bates will challenge the conference attendees and will expose where both traditional market research and ROI can go wrong when used to guide marketing decisions return. She will also provide attendees with ideas on how to utilize market research data to provide input into ROI measurement for their marketing teams.

Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. Under Bates' leadership, Eularis issued three related research reports in the past year, including:

"Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line" (http://www.pharmamarketingroi.com/),

"Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?" (http://www.pharmaindustrysfe.com/), and

"Ensuring Profitable Patient Adherence Programs by Effectively Using Analytics to Release the Hidden Value Available to the Bottom Line from Adherence" (http://www.patientadherenceroi.com/).

The 3rd Annual Pharmaceutical Market Research Summit takes place in Philadelphia. The summit program features detailed case studies from some of the industry's most prominent organizations and provides information needed to improve market research initiatives.

About Eularis

Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches which are lengthy and whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling (both professional and consumer), portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Co-headquartered in London and New York City, the company has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.
For more information about Eularis, visit http://www.eularis.com.

All trademarks acknowledged.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Eularis
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report
2. MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
3. MEDIA ALERT: Eularis to Address Marketing Return at Pharmaceutical Marketing Society Half-day Conference: ROI or RIP?
4. Eularis Releases Update of Its Comprehensive Report on Maximizing the Bottom Line in Pharmaceutical Marketing
5. Eularis Announces New Corporate Name and Expanded Product Offerings
6. Adaptis Launches New Website and URL Address
7. APIC Conference to Address New CMS Regulations
8. APIC Conference to address new CMS regulations
9. Siemens Addresses Cost vs. Value Issues In Healthcare and Technology
10. Video: National Association of School Nurses Launches Educational Program to Address Surge of Prescription Drug Abuse by Americas Youth
11. AWWA Urges Science-Based Approach in Addressing Pharmaceutical Compounds in Water
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: